Harmonizing the use of adverse-drug reaction terms: Definitions of terms and minimum requirements for their use: Respiratory disorders and skin disorders

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 2, 1997, Pages 115-127

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARDIOVASCULAR AGENT; CYCLOPHOSPHAMIDE; GOLD; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; NITROFURANTOIN; PENICILLIN DERIVATIVE; PHENYLBUTAZONE; SALAZOSULFAPYRIDINE; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ADVERSE DRUG REACTION; APNEA; ARTICLE; ASPHYXIA; ASTHMA; BRADYPNEA; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; DYSPNEA; HUMAN; HYPOVENTILATION; HYPOXIA; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; NOMENCLATURE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY ARREST; RESPIRATORY TRACT DISEASE; SKIN MANIFESTATION;

EID: 0031001444     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199703)6:2<115::AID-PDS252>3.0.CO;2-X     Document Type: Article

References (9)

1. Final Report of CIOMS Working Group. International Reporting of Adverse Drug Reactions. CIOMS, Geneva, 1990.
2. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an International Consensus Meeting. International Journal of Clinical Pharmacology, Therapy and Toxicology 1990; 28(8): 317-322.
3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia. International Journal of Clinical Pharmacology, Therapy and Toxicology 1991; 29(2): 75-81.
4. Basic requirements for the use of terms for reporting adverse drug reactions. Anaphylactic shock, arrhythmia, cardiac failure, hypertension, thrombosis and embolism. Pharmacoepidemiology and Drug Safety 1992; 1: 39-45.
5. Basic requirements for the use of terms for reporting adverse drug reactions (II). Colitis, gastrointestinal haemorrhage, hepatocellular damage, peptic ulcer, pancreatitis. Pharmacoepidemiology and Drug Safety 1992; 1: 133-137.
6. Basic requirements for the use of terms for reporting adverse drug reactions (III). Aplastic anaemia, bone marrow depression, coagulation disorders, agranulocytosis, thrombophlebitis. Pharmacoepidemiology and Drug Safety 1992; 1: 191-196.
7. Basic requirements for the use of terms for reporting adverse drug reactions (IV). Diskinesia, depression, myopathy, neuropathy, paralysis, convulsions. Pharmacoepidemiology and Drug Safety 1993; 2: 149-153.
8. Basic requirements for the use of terms for reporting adverse drug reactions (V). Vision abnormal, keratitis, cataract, retinal disorder acidosis. Pharmacoepidemiology and Drug Safety 1994; 2: 189-193.
9. Definition of adverse drug reactions and minimum requirements for their use (myocardial, endocardial, pericardial and valve disorders). Pharmacoepidemiology and Drug Safety 1994; 2: 591-602.